Products

TAXUS® Liberté® Long
Paclitaxel-Eluting Coronary Stent System

Advancing Stent Design for Drug Delivery in Long Lesions

Introducing the TAXUS Liberté Long Stent System, the only 38mm length drug-eluting stent (DES) approved for use in the United States.

Engineered for Consistent Drug Distribution
  • Unique, uniform repeating cell geometry supports even drug distribution and delivery
  • Hybrid cell design allows for strength, flexibility and conformability
Drug Distribution

Designed for Improved Deliverability in Long Lesions
  • 27% thinner struts (0.0038")¹
  • Low stent crossing profile (0.046")
  • Lowest tip profile (0.017")
  • 10% more trackable stent delivery system¹
Improved Stent Apposition and Uniform Neointimal Coverage
  • 25% more uniform neointimal coverage and improved stent apposition²
  • Consistent low levels of neointimal volume
Drug Distribution

Additional Product Information

Order Number
Monorail® Catheter		 Order Number
Over-the-Wire Catheter		 Nominal Expanded
Stent Inner Diameter		 Nominal Unexpanded
Stent Length
H7493893638270 H7493893738270 2.75mm 38mm
H7493893638300 H7493893738300 3.00mm 38mm
H7493893638350 H7493893738350 3.50mm 38mm
H7493893638400 H7493893738400 4.00mm 38mm


The C-code used for the TAXUS Liberté Long Stent is C1874: Stent, coated/covered, with delivery system. C-codes are used for hospital outpatient device reporting for Medicare and some private payers.

Note: Boston Scientific is not responsible for the correct use of codes on submitted claims; this information does not constitute reimbursement or legal advice.

* Computer modeling of drug distribution uniformity in vascular tissue. Modeling results are for demonstration purposes only and may not necessarily be indicative of clinical performance. Testing completed by Boston Scientific Corporation. Data on file.
¹ As compared to the TAXUS® Express²® Stent System. Testing completed by Boston Scientific Corporation. Data on file.
² As compared to the TAXUS Express Stent System from the TAXUS ATLAS Trial.

All claims based on bench test data. Testing completed by Boston Scientific Corporation. Data on file. Bench test results not necessarily indicative of clinical performance.